Tag: Dr Sharon Chinthrajah
FDA Accepts Investigational New Drug Application for Novel Peanut Allergy Therapy
The company, which is already in phase 2 clinical trials with a treatment for celiac disease, has announced the FDA has accepted their Investigational New Drug (IND) application for evaluation of CNP-201, A treatment for peanut allergy. that reduces the need for strict peanut avoidance and reduces the potentially fatal health risks associated with peanut allergy.
Study: Antibody Injection Stops Peanut Allergy for 2 to 6 Weeks
A Stanford-led pilot study has provided early evidence that an antibody is a safe, effective and rapid food allergy treatment.
Clinical Trial to Evaluate Experimental Treatment in People Allergic to Multiple...
NIH and partners to assess whether Omalizumab can reduce allergic reactions.
Study: Drug Increases Speed and Safety of OIT for Multiple Allergies
Combining omalizumab with OIT is safe and effective for treating multiple food allergies simultaneously.
